Global epidemiology of alcohol-related liver disease, liver cancer, and alcohol use disorder, 2000–2021
Texas Tech University · Texas Tech University Health Sciences Center · +26 more institutions
Abstract
We registered the global and regional trends of AUD, ALD, and alcohol-related liver cancer using data from the Global Burden of Disease 2021 Study, the largest and most up-to-date global epidemiology database. We estimated the annual percent change (APC) and its 95% confidence interval (CI) to assess changes in age-standardized rates over time.
In 2021, there were 111.12 million cases of AUD, 3.02 million cases of ALD, and 132,030 cases of alcohol-attributable primary liver cancer. Between 2000 and 2021, there was a 14.66% increase in AUD, a 38.68% increase in ALD, and a 94.12% increase in alcohol-attributable primary liver cancer prevalence. While the age-standardized prevalence rate for liver cancer from alcohol increased (APC 0.59%; 95% confidence interval [CI] 0.52 to 0.67%) over these years, it decreased for ALD (APC -0.71%; 95% CI -0.75 to -0.67%) and AUD (APC -0.90%; 95% CI -0.94 to -0.86%). There was significant variation by region, socioeconomic development level, and sex. During the last years (2019-2021), the prevalence, incidence, and death of ALD increased to a greater extent in females.
Citation impact
- FWCI
- 56.58
- Percentile
- 100%
- References
- 48
Authors
23- PDPojsakorn Danpanichkul
Texas Tech University, Texas Tech University Health Sciences Center
- LALuis Antonio Díaz
Pontificia Universidad Católica de Chile, University of California San Diego
- KSKanokphong Suparan
Chiang Mai University
- PTPrimrose Tothanarungroj
Chiang Mai University
- SSSupapitch Sirimangklanurak
Chiang Mai University
Topics & keywords
- Medicine
- Epidemiology
- Liver cancer
- Liver disease
- Alcohol use disorder
- Alcohol
- Internal medicine
- Cancer
- Good health and well-being
Funding
- IFInstitute for Health Metrics and Evaluation
- CDCentres de Recerca de CatalunyaAward: 501100011033
- GDGeneralitat de CatalunyaAwards: 10.13039/501100011033, CEX2023-0001290-S, 501100011033, MCIN/AEI/ 10.13039/501100011033
- NINational Institutes of HealthAwards: P30DK120515, 5UL1TR001442
- AEAgencia Estatal de InvestigaciónAwards: 501100011033, 10.13039/501100011033, AEI/ 10.13039/501100011033, CEX2023-0001290-S, 13039, 10.13039, 13039/501100011033, MCIN/AEI/ 10.13039/501100011033
- NINational Institute on Alcohol Abuse and AlcoholismAward: U01AA029019
- NHNational Heart, Lung, and Blood InstituteAwards: P30DK120515, U01AA029019, P01HL147835
- NINational Institute on Drug Abuse
- NINational Institute of Diabetes and Digestive and Kidney DiseasesAward: P30DK120515
- NCNational Center for Advancing Translational SciencesAwards: P30DK120515, 5UL1TR001442